Everolimus in Refractory Testicular Germ Cell Cancer

NCT01466231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Germ Cell Tumor

Interventions

DRUG: Everolimus

Sponsor

National Cancer Institute, Slovakia